These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pharmacological interventions for hypertension in children. Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305 [TBL] [Abstract][Full Text] [Related]
5. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Abalos E; Duley L; Steyn DW; Gialdini C Cochrane Database Syst Rev; 2018 Oct; 10(10):CD002252. PubMed ID: 30277556 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and renal protection in type 2 diabetes mellitus: the role of calcium channel blockers. Nosadini R; Tonolo G J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S216-23. PubMed ID: 12466317 [TBL] [Abstract][Full Text] [Related]
7. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154 [TBL] [Abstract][Full Text] [Related]
8. Cochrane in context: pharmacological interventions for hypertension in children. Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306 [TBL] [Abstract][Full Text] [Related]
9. Blood pressure lowering effect of calcium channel blockers on perioperative hypertension: A systematic review and meta-analysis. Lin Y; Ma L Medicine (Baltimore); 2018 Nov; 97(48):e13152. PubMed ID: 30508892 [TBL] [Abstract][Full Text] [Related]
10. Effect of longer-term modest salt reduction on blood pressure. He FJ; Li J; Macgregor GA Cochrane Database Syst Rev; 2013 Apr; (4):CD004937. PubMed ID: 23633321 [TBL] [Abstract][Full Text] [Related]
11. Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study. Ruilope LM; Usan L; Segura J; Bakris GL J Hypertens; 2004 Jan; 22(1):217-22. PubMed ID: 15106814 [TBL] [Abstract][Full Text] [Related]
12. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients]. Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. Staessen JA; Wang JG; Thijs L J Hypertens; 2003 Jun; 21(6):1055-76. PubMed ID: 12777939 [TBL] [Abstract][Full Text] [Related]
14. Antihypertensive treatment with calcium channel blockers in patients with moderate or severe aortic stenosis: Relationship with all-cause mortality. Saeed S; Mancia G; Rajani R; Parkin D; Chambers JB Int J Cardiol; 2020 Jan; 298():122-125. PubMed ID: 31575497 [TBL] [Abstract][Full Text] [Related]
15. Registry of the Egyptian specialized hypertension clinics: Sex-related differences in clinical characteristics and hypertension management among low socioeconomic hypertensive patients. Abdel Aal A; Youssef G; El Faramawy A; El Remisy D; El Deeb H; El Aroussy W; Ibrahim MM J Clin Hypertens (Greenwich); 2021 Jun; 23(6):1120-1128. PubMed ID: 33774923 [TBL] [Abstract][Full Text] [Related]
16. Morning versus evening administration of a calcium channel blocker in combination therapy for essential hypertension by ambulatory blood pressure monitoring analysis. Chu CS; Lee KT; Chen SH; Lu YH; Lin TH; Voon WC; Sheu SH; Lai WT Int Heart J; 2005 May; 46(3):433-42. PubMed ID: 16043939 [TBL] [Abstract][Full Text] [Related]
17. Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease. Huang RS; Cheng YM; Zeng XX; Kim S; Fu P Chin Med J (Engl); 2016 Mar; 129(5):562-9. PubMed ID: 26904991 [TBL] [Abstract][Full Text] [Related]
18. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults. Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of dual calcium channel blockade for the treatment of hypertension: a meta-analysis. Alviar CL; Devarapally S; Nadkarni GN; Romero J; Benjo AM; Javed F; Doherty B; Kang H; Bangalore S; Messerli FH Am J Hypertens; 2013 Feb; 26(2):287-97. PubMed ID: 23382415 [TBL] [Abstract][Full Text] [Related]
20. Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension. Chen JM; Heran BS; Perez MI; Wright JM Cochrane Database Syst Rev; 2010 Jan; (1):CD007185. PubMed ID: 20091622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]